Background: Cannabis use is a potential risk factor for respiratory disease but its role apart from tobacco use is unclear. We evaluated the association between regular cannabis use, with and without tobacco co-use, and onset of asthma, chronic obstructive pulmonary disease (COPD), and pneumonia.
Methods: Analysis of a limited data set obtained through IBM Watson Health Explorys, an electronic-health-record-integration platform. Matched controls using Mahalanobis distance within propensity score calipers were defined for: 1) cannabis-using patients (n = 8932); and subgroups of cannabis-using patients: 2) with an encounter diagnosis for tobacco use disorder (TUD; n = 4678); and 3) without a TUD diagnosis (non-TUD; n = 4254). Patients had at least: one recorded blood pressure measurement and one blood chemistry lab result in the MetroHealth System (Cleveland, Ohio). Cannabis-using patients had an encounter diagnosis of cannabis abuse/dependence and/or ≥2 cannabis-positive urine drug screens (UDSs). Control patients, not having cannabis-related diagnoses or cannabis-positive UDSs, were matched to the cannabis-using patients on demographics, residential zip code median income, body mass index, and, for the total sample, TUD-status.
Results: Regular cannabis use was significantly associated with greater risk for asthma (odds ratio (OR) = 1.44; adjusted odds ratio (aOR) = 1.50; OR = 1.32), COPD (OR = 1.56; aOR = 1.44; OR = 2.17), and pneumonia (OR = 1.80; OR = 1.84; OR = 2.13) in the total sample and TUD and non-TUD subgroups, respectively. TUD-patients had the greatest prevalence of respiratory disease, regardless of cannabis-use indication.
Conclusions: Regular cannabis use is associated with significantly greater risk of respiratory disease regardless of TUD status. Future research to understand the impact of cannabis use on respiratory health is warranted.
Keywords: Cannabis; Electronic Health Record (EHR); Respiratory.
Copyright © 2019 Elsevier B.V. All rights reserved.
Conflict of interest statement
The association between regular cannabis use, with and without tobacco co-use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non-tobacco smokers.Am J Drug Alcohol Abuse. 2019 Nov 19:1-8. doi: 10.1080/00952990.2019.1676433. Online ahead of print. Am J Drug Alcohol Abuse. 2019. PMID: 31743053
Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.Addiction. 2019 Aug;114(8):1462-1470. doi: 10.1111/add.14607. Epub 2019 Apr 25. Addiction. 2019. PMID: 30851217
Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.J Dual Diagn. 2018 Jul-Sep;14(3):171-180. doi: 10.1080/15504263.2018.1470359. Epub 2018 Sep 28. J Dual Diagn. 2018. PMID: 30265850
Clinical correlates of co-occurring cannabis and tobacco use: a systematic review.Addiction. 2012 Aug;107(8):1404-17. doi: 10.1111/j.1360-0443.2012.03843.x. Epub 2012 Apr 17. Addiction. 2012. PMID: 22340422 Free PMC article. Review.
What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?Addiction. 2015 Jan;110(1):19-35. doi: 10.1111/add.12703. Epub 2014 Oct 7. Addiction. 2015. PMID: 25287883 Review.